# Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease

> **NCT00095355** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 35 (—)

## Conditions studied

- Huntington's Disease

## Interventions

- **DRUG:** Lithium
- **DRUG:** Divalproex

## Key facts

- **NCT ID:** NCT00095355
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 35 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00095355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00095355, "Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00095355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*